Fundraising Fox

Mable

YC S21

London, GB · Founded 2019 · 7 employees · Acquired · 4 known investors

trymable.com ↗

Mable is a genomics-based telehealth platform that provides personalized migraine care by analyzing patients' genetic and biomarker data to inform individualized treatment plans. The company serves migraine sufferers seeking precision medicine alternatives to traditional trial-and-error medication approaches.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesHealth TechTelehealthGenomicsin /mable-health@mablehealth

Founders & leadership· Y Combinator alumni (S21)

Roman Rothaermel
Roman RothaermelinCEO
Inna Thalmann
Inna ThalmanninFounder
IN
Inna Nicole Thalmann
CE
Chris Eijsbouts
KG
Kumeren Govnder

Investors · 4

Initialized Capital✓ verifiedSan Francisco
Underscore VCBoston
Y CombinatorMountain View · $500K – $500K
VenrockreportedPalo Alto

In the news